1933 Industries Inc. (OTCQX:TGIFF)

At the end of Prohibition. At the forefront of a New Beginning.

1933 Industries’ objective is to capitalize on the opportunities resulting from the end of cannabis prohibition in Canada and the legalization of the industry in several US States. The Company is focused on its consumer-packaged goods business and has established a foothold in several distinct parts of the value chain of the North American medical and adult use cannabis industry. The Company will replicate this model in other jurisdictions where permitted by law or regulation.

1933 Industries is a vertically-integrated, growth-orientated company, focusing on the cultivation and manufacturing of cannabis consumer branded goods in a wide range of product formats. Operating through two subsidiaries, the Company controls all aspects of the value chain with cultivation, extraction, processing, and manufacturing assets supporting its diversified portfolio of cannabis brands and licensing partners.

Our award-winning proprietary portfolio of brands include: AMA flower and AMA concentrates as well as CBD-infused Canna Hemp™, Canna Hemp X™, and Canna Fused™ products. Partners under licensing agreements include: Birdhouse Skateboards™, Blonde™ Cannabis, Bloom™, Denver Dab Co., Grizzly Griptape, OG DNA Genetics, The Pantry Company, PLUGplay, and The Original Jack Herer®.

The Company owns 91% of Alternative Medicine Association, LC (AMA), a licensed medical and adult-use cannabis cultivation and extraction subsidiary that produces its own AMA branded line of unique cannabis-based products and manufactures third-party brands. Infused MFG, a wholly-owned subsidiary, produces the Canna Hemp™ line of hemp-based, CBD products, thoughtfully crafted of high-quality organic botanical ingredients.

1933 Industries continues to focus its operations in the licensed US cannabis industry as a multi-state operator in Nevada, Colorado and California.

-BUSINESS STRATEGY

-Strengthen and expand current operations
-Introduce the Company’s brands into new and upcoming markets
-Identify targets for acquisition in favorable jurisdictions
-Develop and identify products that would benefit from THC and CBD additives.
-Ensure proper capitalization to strike where opportunities are available.

-LEADING POSITION AND FIRST-MOVER ADVANTAGE IN LAS VEGAS
-First licensed cultivator in Las Vegas
-Longest growing history of any medical marijuana establishment in Nevada
-Holder of licenses for cultivation and production
-Required infrastructure in place to rapidly scale up cannabis production

-ESTABLISHED CONSUMER PRODUCTS

-Strong foothold in both legalized cannabis from cannabidiol (CBD) and tetrahydrocannabinol (THC) products
-Established brand identity and consumer loyalty with growing sales and margins
-Growth of CBD due to its potential therapeutic applications for a variety of conditions
-Huge opportunity in hemp-derived CBD and high-quality CBD branded products that have wide appeal
-Establishing hemp-processing and CBD extraction vertical with few competitors in the market

-EXPANDING CAPACITY

-Completed cultivation expansion from 12,000 sq. ft. total capacity to a state-of-the-art, newly built 67,750 sq. ft. cultivation-only facility
-Expanding extraction capacity and production space to 12,160 sq. ft.
-Establishing a new hemp processing facility to produce CBD extracts for full spectrum oils, distillates and isolates

-CANNABIS EXPERTS. LIFELONG ENTREPRENEURS.

-Operational expertise with cannabis industry and public market professionals
-Leadership includes long-time cultivators, cosmetic industry professionals, regulators, marketers and financiers.

-MARKETS

-U.S. cannabis industry is projected to exceed $50 billion in size by 2026 (Cowen & Co.), driven by the legalization of recreational cannabis in many states.

-Canada’s market is projected to reach C$22.6 billion over the coming years (Deloitte).

1933 Industries Inc. is a publicly traded company listed on the OTCQX under the ticker symbol TGIFF. This is not investment advice. Please view the disclaimer found on this website.